Updated Mandatory Notices (-01028) - remove K. Canfield as counsel | Dec 11, 2018 | PAPER | PATENT OWNER |
Patent Owners' Notice of Appeal IPR2016-01028 | Dec 4, 2017 | PAPER | PATENT OWNER |
Final Written Decision - Determining That Claim 1 Has Been Shown To Be Unpatentable | Nov 8, 2017 | PAPER | BOARD |
Parties (August 10th 2017) Email Construction Agreement Regarding the Term Core Matrix | Nov 2, 2017 | EXHIBIT | BOARD |
Hearing Transcript | Oct 6, 2017 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices Pursuant To 37 C.F.R. 42.8(a)(3) | Sep 27, 2017 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Jul 31, 2017 | PAPER | PETITIONER |
Patent Owners' Demonstratives IPR2016-01028 | Jul 26, 2017 | PAPER | PATENT OWNER |
Petitioner's Demonstratives for Oral Argument | Jul 26, 2017 | PAPER | PETITIONER |
Patent Owners' Reply in Support of Motion to Exclude | Jul 20, 2017 | PAPER | PATENT OWNER |
Reply To Patent Owners' Opposition To Petitioner's Motion To Exclude Evidence | Jul 20, 2017 | PAPER | PETITIONER |
Patent Owners' Surreply IPR2016-01028 | Jul 14, 2017 | PAPER | PATENT OWNER |
Patent Owners' Opposition to Motion to Exclude (2016-01028) | Jul 13, 2017 | PAPER | PATENT OWNER |
2150 Application No. 14728601 Jan 26 2017 Non Final Rejection | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
2151 Application No. 14725601 Final Rejection | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
2153 Application No. 14733659 Jan 18 2017 Non Final Rejection | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
Patent Owners' Updated Exhibit List (2016-01027,-01028) | Jul 13, 2017 | PAPER | PATENT OWNER |
2149 Application No. 14728601 Dec 8 2016 RCE | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
2152 Application No. 14733659 Dec 15 2016 RCE | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
2154 Application No. 14733659 Final Rejection | Jul 13, 2017 | EXHIBIT | PATENT OWNER |
Response to Patent Owners Observations on Cross Examination of Dr. Robert J. Timko | Jul 13, 2017 | PAPER | PETITIONER |
Response to Patent Owners' Observations on Cross Examination of Dr. Thomas Vander Veen | Jul 13, 2017 | PAPER | PETITIONER |
Opposition to Patent Owners' Motion to Exclude | Jul 13, 2017 | PAPER | PETITIONER |
Patent Owners' Updated Mandatory Notice (-01028) | Jul 12, 2017 | PAPER | PATENT OWNER |
Order - re Conference Call (7/3/2017) | Jul 7, 2017 | PAPER | BOARD |
Oral Hearing Order | Jul 7, 2017 | PAPER | BOARD |
Patent Owners' Motion to Exclude Evidence | Jun 30, 2017 | PAPER | PATENT OWNER |
U.S. Patent Application No. 08/864,306 | Jun 30, 2017 | EXHIBIT | PATENT OWNER |
Combined Declaration and Power of Attorney for U.S. Patent
Application No. 11/939,585 | Jun 30, 2017 | EXHIBIT | PATENT OWNER |
U.S. Patent Application Publication No. 2008/0287418 | Jun 30, 2017 | EXHIBIT | PATENT OWNER |
Deposition of Dr. Timko (June 22, 2017) | Jun 30, 2017 | EXHIBIT | PATENT OWNER |
Deposition of Dr. Vander Veen (June 27, 2017) | Jun 30, 2017 | EXHIBIT | PATENT OWNER |
Patent Owners' Updated Exhibit List | Jun 30, 2017 | PAPER | PATENT OWNER |
Patent Owner - Observations on Vander Veen Cross-Examination | Jun 30, 2017 | PAPER | PATENT OWNER |
Patent Owners' Observations on Timko Cross Examination | Jun 30, 2017 | PAPER | PATENT OWNER |
Petitioner¿¿¿s Motion to Exclude Evidence Pursuant to 37 C.F.R. ¿¿ 42.64(c) | Jun 30, 2017 | PAPER | PETITIONER |
Patent Owners' Request for Oral Hearing (IPR2016-01028) | Jun 29, 2017 | PAPER | PATENT OWNER |
PETITIONER¿¿¿S REQUEST FOR ORAL ARGUMENT | Jun 29, 2017 | PAPER | PETITIONER |
Patent Owners' Notice of Deposition of Dr. Timko | May 30, 2017 | PAPER | PATENT OWNER |
Patent Owners' Notice of Deposition of Dr. Vander Veen | May 30, 2017 | PAPER | PATENT OWNER |
Purdue Pharma L.P. et al. v. Teva Pharmaceuticals LLC, No. 11-cv-2037 and 12-cv-5083 (S.D.N.Y. Jan. 14, 2014) Finding of Facts and Conclusion of Law | May 25, 2017 | EXHIBIT | PETITIONER |
Petitioner's Exhibit List | May 25, 2017 | PAPER | PETITIONER |
Patent Owners' Objections to Evidence After Institution | May 22, 2017 | PAPER | PATENT OWNER |
Curriculum Vitae of Robert Timko, Ph.D. | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,034,376 | May 15, 2017 | EXHIBIT | PETITIONER |
Apicella et al. | May 15, 2017 | EXHIBIT | PETITIONER |
Brunella Cappello et al. | May 15, 2017 | EXHIBIT | PETITIONER |
Declaration of Dr. Thomas Vander Veen | May 15, 2017 | EXHIBIT | PETITIONER |
Curriculum Vitae of Thomas Vander Veen, Ph.D. | May 15, 2017 | EXHIBIT | PETITIONER |
Dimitrov and Lambov | May 15, 2017 | EXHIBIT | PETITIONER |
Efentakis and Vlachou | May 15, 2017 | EXHIBIT | PETITIONER |
Cherng ju Kim, Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets | May 15, 2017 | EXHIBIT | PETITIONER |
Yang et al. | May 15, 2017 | EXHIBIT | PETITIONER |
Follonier et al. | May 15, 2017 | EXHIBIT | PETITIONER |
PDR - REVIA, DILAUDID, TYLOX, TALWIN | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,266,331 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,178,878 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 3,822,343 | May 15, 2017 | EXHIBIT | PETITIONER |
Remington Ch. 92 - Lubricants | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,948,437 | May 15, 2017 | EXHIBIT | PETITIONER |
Maniruzzaman et al. | May 15, 2017 | EXHIBIT | PETITIONER |
Oxycodone, Merck Index 1194 (12 ed. 1996) | May 15, 2017 | EXHIBIT | PETITIONER |
Bailey et al., POLYOX, High Molecular Weight Polymers of Ethylene Oxide | May 15, 2017 | EXHIBIT | PETITIONER |
Guidance for Industry: SUPAC MR | May 15, 2017 | EXHIBIT | PETITIONER |
Remington Ch. 94 - Sustained Release Drug Delivery System | May 15, 2017 | EXHIBIT | PETITIONER |
Chernug ju Kim, Research Article, Effects of Drug Solubility, Drug Loading | May 15, 2017 | EXHIBIT | PETITIONER |
Moroni and Ghebre Sellassie | May 15, 2017 | EXHIBIT | PETITIONER |
Carstensen | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,223,264 | May 15, 2017 | EXHIBIT | PETITIONER |
Remington Ch. 93 - Coating of Pharmaceutical Dosage Forms | May 15, 2017 | EXHIBIT | PETITIONER |
Zasypkin et al. | May 15, 2017 | EXHIBIT | PETITIONER |
Meunier, Multicomponent Biopolymer Gels: The Agarose-Carraeenan-Gellan System | May 15, 2017 | EXHIBIT | PETITIONER |
David and Stewart, Ch.9 Commercial Success: Economic Principles Applied to Patent Litigation | May 15, 2017 | EXHIBIT | PETITIONER |
Crouch, Objective Indicia on Non-Obviousness Must be Tied to Inventive Step | May 15, 2017 | EXHIBIT | PETITIONER |
Kolassa, Elements of Pharmaceutical Pricing | May 15, 2017 | EXHIBIT | PETITIONER |
Gunul et al., Promotion of Prescription Drugs and Its Impact on Physicians¿¿¿ Choice Behavior | May 15, 2017 | EXHIBIT | PETITIONER |
Manual of Patent Examining Procedure Sect. 716.03 | May 15, 2017 | EXHIBIT | PETITIONER |
Approved Drug Products with Therapeutic Equivalence Evaluations | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,776,314 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,114,383 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,309,060 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,894,987 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,492,389 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,492,392 | May 15, 2017 | EXHIBIT | PETITIONER |
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations | May 15, 2017 | EXHIBIT | PETITIONER |
Chisum on Patents A Treatise on the Law of Patentability, Validity and Infringement, Sect. 5.05 | May 15, 2017 | EXHIBIT | PETITIONER |
Guha et al., The Economics of Commercial Success in Pharmaceutial Patent Litigation | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,804,741 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,894,988 | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,492,391 | May 15, 2017 | EXHIBIT | PETITIONER |
Bernstein and Higham, Senator to investigate opioid makers¿¿¿ role in drug crisis | May 15, 2017 | EXHIBIT | PETITIONER |
Time for opioid makers to come clean and help addicts go clean | May 15, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,492,393 | May 15, 2017 | EXHIBIT | PETITIONER |
Brief of Plaintiffs Appellants, Purdue Pharma L.P. et al. v. Epic Pharma, LLC, Appeal No. 2014 1294 | May 15, 2017 | EXHIBIT | PETITIONER |
Finding of Facts and Conclusion of Law, Purdue Pharma L.P. et al. v. Teva Pharms.USA, Inc. | May 15, 2017 | EXHIBIT | PETITIONER |
Center for Drug Evaluation and Research, Application Number 22 272 | May 15, 2017 | EXHIBIT | PETITIONER |
Guidance for Industry: Abuse-Deterrent Opioids - Evaluation and Labeling | May 15, 2017 | EXHIBIT | PETITIONER |
FDA Perspective on Assessment of Drugs - Abuse Potential & Abuse Deterrence | May 15, 2017 | EXHIBIT | PETITIONER |
Advancements in Opioid Abuse Deterrence | May 15, 2017 | EXHIBIT | PETITIONER |
Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply | May 15, 2017 | EXHIBIT | PETITIONER |
Petitioner's Reply to Patent Owner's Response | May 15, 2017 | PAPER | PETITIONER |
Notice of Joint Stipulation to Modify Due Dates 2 and 4 | May 5, 2017 | PAPER | PETITIONER |
PETITIONER'S OBJECTIONS UNDER 37 C.F.R. ¿¿ 42.64 TO EVIDENCE SUBMITTED BY PATENT OWNERS POST-INSTITUTION | Feb 15, 2017 | PAPER | PETITIONER |
2095 HPE 3rd ed (2000) TOC and Index | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
Patent Owners' Motion to Seal | Feb 8, 2017 | PAPER | PATENT OWNER |
Patent Owner Response | Feb 8, 2017 | PAPER | PATENT OWNER |
2096 Byrn Declaration ISO Patent Owner Response to Petition | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2098 Wright Declaration in Support of Patent Owner's Response | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2099 Deposition of Dr. Palmieri (January 13, 2017) | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2100 U.S. Patent No. 5,508,042 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2101 U.S. Patent No. 5,549,912 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2103 U.S. Patent No. 5,656,295 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2104 CONFIDENTIAL Opioid-X Summit slides (April 24, 2001) | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2105 CONFIDENTIAL Excerpts from Purdue Pharma L.P. Notebook No. 394 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2107 CONFIDENTIAL Excerpts from Purdue Pharma L.P. Notebook No. 491 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2108 CONFIDENTIAL Excerpts from Purdue Pharma L.P. Notebook No. 495 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2111 Frederichs - Opioids overview Buschmann, Friderichs 2002 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2113 Zhang - 4 Pharm Dev Technol 241 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2116 Follonier - 20 Drug Dev Ind Pharm 1323 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2124 McGary - 46 J Polym Sci 51 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2136 Downie - 7 Hospital Pharmacist 242 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2141 U.S. Patent No. 6,067,749 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2142 Byrn - Solid State Acid Base Reactions | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2097 Oshlack Declaration in Support of Patent Owner's Response | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2102 U.S. Patent No. 5,266,331 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2106 CONFIDENTIAL Excerpts from Purdue Pharma L.P. Notebook No. 503 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2109 Severtson - 168 Drug and Alcohol Dep 219 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2110 Coplan - 100 Clin Pharm Therap 275 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2112 FDA Guidance for Industry 1997 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2114 Zhang - 26 Drug Dev Ind Pharm 931 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2115 McGinity - 4 Am Pharm Rev 25 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2118 Crowley - 23 Biomaterials 4241 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2122 Kim - 84 J Pharm Sci 303 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2123 Madorsky - 36 J Polym Sci 183 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2125 Alderman - 5 In¿¿¿l J. Pharm. Tech. Prod. Mfr. 1 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2127 Poyhia - 8 Jnl of Pain and Symptom Mgmt 63 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2128 Salomies - 83 J AOAC Int'l 1497 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2129 U.S. Patent No. 6,177,567 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2130 Brogle - 19 J. Pharm and Biomed. Analysis 669 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2131 Craig - 179 Int'l. J. Pharm. 179 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2132 Handbook of Pharmaceutical (Magnesium Stearate) | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2133 Ragnarsson - 3 Int'l. J. Pharm. 127 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2134 Murthy - 66 J Pharm Sci 1215 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2135 Bossert - 6 Drug Dev. + Indus. Pharm. 573 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2137 Brookoff - 8 Jnl of General Internal Medicine 688 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2138 Chernin - Painkillers and Pill Popping | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2139 Thompson - 58 Am Jnl of Health-System Pharmacy 956 | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2140 Letter to Pablo Hendler | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
2143 Baker - Controlled Release of Biologically Active Agents (1987) | Feb 8, 2017 | EXHIBIT | PATENT OWNER |
Joint Motion for Entry of Stipulated Protective Order | Nov 15, 2016 | PAPER | PATENT OWNER |
Decision - Institution of Inter Partes Review | Nov 9, 2016 | PAPER | BOARD |
Scheduling Order | Nov 9, 2016 | PAPER | BOARD |
Order - Patent Owner's Motions for Pro Hac Vice Admission | Aug 31, 2016 | PAPER | BOARD |
2001 Interference 106,004 Request Adverse Judgment | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2002 '324 FH Misc. Action 2014-04-07 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2004 '324 FH IDS 2013-06-05 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2006 '324 FH Eaminer Refs 2015-05-12 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2008 OxyContin labeling 8-2015 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2009 '324 FH Comments on 2nd NOA 2015-05-18 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2003 Interference 106,004 Judgment | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2005 '324 FH Examiner Refs 2013-07-09 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2010 '449 FH Amendment 2012-10-01 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2011 14-728,601 FH NOA 2016-03-10 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2012 CPDD Paper 2003 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2016 OxyContin labeling 4-2013 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2018 Levina, Effect of drug and excipients on release | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2022 '324 FH Examiner Refs 2015-05-12 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2023 Joshi WO_2002_087558_A1 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2027 QOS 10-40mg (excerpt) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2029 PolyOx brochure | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2030 Attorneys General letter | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2031 Scheirs, Solid state degradation of PEO | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2039 Maurin Testimony | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2014 Cicero 2016 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2015 UCM332288 (FDA opioid timeline) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2017 FDA Determination 2013-04-16 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2019 Vazquez, Influence of technological variables on release of drugs... | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2020 MW 'core' 2001 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2021 '324 FH IDS 2015-01-05 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2024 CPDD Article - author info | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2025 FDA Devel. Reg. Abuse-Deterrent Opioid 2014-10-30 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2028 QOS 60-80mg (excerpt) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2032 Abuse-Deterrent Opioids draft guidance | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2033 Throckmorton, FDA Voice | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2034 14-733,659 FH NOA 2016-08-01 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2035 HPE-3rd Gelling agents | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2036 HPE-3rd Lubricants | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2037 HPE-3rd Plasticizers | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2038 Merck Index | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2040 5549912 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2044 2_PBT003210922_PBT05 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2045 2012 Endo press release announcing reformulation | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2046 ADFs-A Tale of Two ADFs-TJ Cicero Pain 2016 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2047 FDA Statement Original Opana ER Relisting Determination | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2049 FDA orange book | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2052 Endo announces Opana first launch | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2053 Butler 2013, Abuse rates and routes | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2054 Actavis press release | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2055 Endo to FDA, Opana reformulation citizen petition | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2056 ERO monthly TRx and Sales by product Jan 1992 - Jun 2016_072516 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2060 2011.08.25 Nucynta ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2007 Byrn Declaration (1028) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2048 Chou 2009, Clinical Guidelines for the Use of Chronic Opioid Therapy | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2051 FDA approves abuse-deterrent labeling for reformulated OxyContin | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2057 2010.04.05 Oxycontin | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2058 2010.06.30 Butrans Approval | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2059 2011.04.20 Opana ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2061 2009.07.31 Duragesic | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2063 2013.10.25 Zohydro ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2064 2007.04.20 Kadian | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2065 2010.03.01 Exalgo | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2066 2009.08.13 Embeda | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2070 2010.05.11 MS Contin | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2071 2008.02.20 Ultram ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2062 2014.11.20 Hysingla ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2067 2010.05.07 Conzip | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2068 2014.03.11 Xartemis XR | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2069 2012.07.09 Avinza | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2073 2012.07.09 Dolophine | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2075 2008.12.30 Ryzolt | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2079 2015.10.20 Generic Tramadol HCl ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2080 2014.04.16 Generic oxymorphone HCl | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2081 2004.03.24 Generic oxycodone ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2082 Generic Hydromorpohone HCl ER | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2084 0PO571 (C8559) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2086 May 2008 AdComm minutes | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2089 UCM183205 2009 AdComm FDA briefing doc | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2072 2014.04 Methadose tablet | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2074 2007.05 Oramorph SR | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2076 1998.07.02 Generic morphine sulfate | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2077 2014.05 Generic fentanyl patch | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2078 2015.04 Generic methadone HCl tablet | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2083 Sessler et al 2014, Reductions in reported deaths following... | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2085 C8275 OXY field card | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2087 Weingarten Testimony | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2088 Sept. 2009 Purdue AdCom slides | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2090 UCM187629 2009 AdComm Minutes | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2092 Oshlack Testimony | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2093 Wright Testimony | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
Preliminary Response 1028 | Aug 12, 2016 | PAPER | PATENT OWNER |
2041 CONFIDENTIAL Expert Declaration of Eric M. Gaier PhD | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2091 PDR 1997 | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
2094 Proposed Protective Order (1028) | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
IPR2016-01028 Patent Owner's Motion To Seal | Aug 12, 2016 | PAPER | PATENT OWNER |
2041 PUBLIC Expert Declaration of Eric M. Gaier PhD_Redacted | Aug 12, 2016 | EXHIBIT | PATENT OWNER |
Amneal IPR - Normile Pro Hac Motion (IPR2016-01028) | Jun 14, 2016 | PAPER | PATENT OWNER |
Amneal IPR - Winchester Pro Hac Motion (IPR2016-01028) | Jun 14, 2016 | PAPER | PATENT OWNER |
Amneal IPR - Mandatory Notices (IPR2016-01028) | May 31, 2016 | PAPER | PATENT OWNER |
Power of Attorney | May 27, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | May 12, 2016 | PAPER | BOARD |
Transmittal letter regarding exhibits | May 11, 2016 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 9,060,976 | May 11, 2016 | PAPER | PETITIONER |
Power of Attorney | May 11, 2016 | PAPER | PETITIONER |
U.S. Patent No. 9,060,976 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,337,888 | May 11, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, 13-3372 | May 11, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015-1654 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,101,630 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2010/0216829 | May 11, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, 15-831 | May 11, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC,15-1152 | May 11, 2016 | EXHIBIT | PETITIONER |
Declaration of Dr. Anthony Palmieri | May 11, 2016 | EXHIBIT | PETITIONER |
Curriculum Vitae of Anthony Palmieri, Ph.D. | May 11, 2016 | EXHIBIT | PETITIONER |
International Publication No. WO9932120 | May 11, 2016 | EXHIBIT | PETITIONER |
The Handbook of Pharmaceutical Excipients 399-400, 655 | May 11, 2016 | EXHIBIT | PETITIONER |
International Publication No. WO 97/49384 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2002/0187192 | May 11, 2016 | EXHIBIT | PETITIONER |
International Publication No. WO 95/20947 | May 11, 2016 | EXHIBIT | PETITIONER |
OxyContin, Physicians Desk Reference 2569-74 | May 11, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, 2014-1306 | May 11, 2016 | EXHIBIT | PETITIONER |
Department of Justice, Information Bulletin | May 11, 2016 | EXHIBIT | PETITIONER |
Barry Meier, U.S. Asks Painkiller Maker To Help Curb Wide Abuse | May 11, 2016 | EXHIBIT | PETITIONER |
Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal 2015-1654 | May 11, 2016 | EXHIBIT | PETITIONER |
Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal 2015-1654 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/349,449 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 12/653,115 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 10/214,412 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/310,534 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Preliminary Amendment, Dec. 24, 2012 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Supplemental Amendment, Jan. 23, 2013 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Office Action, July 15, 2013 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Amendment and Response, Jan. 15, 2014 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Notice of Allowance, Oct. 31, 2014 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Request for Continued Examination, Jan. 5, 2015 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Communication from Applicant, Jan. 29, 2015 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Information Disclosure Statement, Apr. 14, 2015 | May 11, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/726,324, Notice of Allowance, May 12, 2015 | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 4,861,598 (Oshlack) | May 11, 2016 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/287,509 | May 11, 2016 | EXHIBIT | PETITIONER |
Oral Dosage Forms, II (94) Remington The Science and Practice of Pharmacy | May 11, 2016 | EXHIBIT | PETITIONER |